Hydroxyurea

Hydroxyurea

SCHEMBL5745587

NC(=O)NO.O=[N+]([O-])O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

RRM1RRM2RRM2B

The experimentally established mechanism targets of Hydroxyurea. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyurea SCHEMBL21083113 0.88 TSHR (0.62)
Nitric Acid SCHEMBL1173278 0.84 CA5A (0.53)
Nitric Acid SCHEMBL1172643 0.81 CA5A (0.50)
Hydrazinecarboxamide SCHEMBL159341 0.81
Hydrazinecarboxamide SCHEMBL31298907 0.81 TSHR (0.62)
Nitric Acid SCHEMBL25282444 0.81 CA5A (0.50)
Urea SCHEMBL1122882 0.79 CA5A (0.67)
Urea SCHEMBL27597938 0.79 CA5A (0.67)
Urea SCHEMBL237222 0.79
Urea SCHEMBL10953403 0.79 CA5A (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109069664-B anti-CD 74 antibody conjugates, compositions comprising anti-CD 74 antibody conjugates, and methods of use of anti-CD 74 antibody conjugates 苏特罗生物制药公司 2022-05-13 CN disclosed
EP-1622929-A2 APO2L (TRAIL) RECEPTOR BINDING PEPTIDES AND USES THEREOF Genentech, Inc. (US) 2006-02-08 EP disclosed
WO-2004101608-A2 APO2L (TRAIL) RECEPTOR BINDING PEPTIDES AND USES THEREOF GENENTECH, INC. (US) 2004-11-25 WO disclosed